Goal 3 - Good health and well-being

The data for this indicator a custom tabulation. Tables 13-10-0152-01 and 13-10-0414-01 are used to derive this indicator which is calculated as follows: (Deaths, by cause: Pregnancy, childbirth and the puerperium divided by live births) multiplied by 100,000.

The data for this indicator a custom tabulation. Tables 13-10-0709-01 and 13-10-0414-01 are used to derive this indicator which is calculated as follows: (Age at time of death, 0 to 4 years divided by live births) multiplied by 1,000.

Rate (per 100,000)

• Male: 9.2
• Female: 2.8
• Men who have sex with men: 356
• Injection drug users: 303

Rate (per 100,000)

• Male: 8.6
• Female: 2.4
• Men who have sex with men: 329
• Injection drug users: 271

Rate (per 100,000)

• Male: 5.24
• Female: 4.45

Rate (per 100,000)

• Male: 5.62
• Female: 4.41

Rate (per 100,000)

• Male: 2.06
• Female: 1.14

Rate (per 100,000)

• Male: 2.08
• Female: 1.22

Rate (per 100,000)

• Male: 14.47
• Female: 11.27

Rate (per 100,000)

• Male: 15.43
• Female: 11.32

Rate (per 100,000)

• Male: 0.05
• Female: 0.01

Rate (per 100,000)

• Male: 0
• Female: 0

Rate (per 100,000)

• Male: 0
• Female: 0

Rate (per 100,000)

• Male: 0
• Female: 0

Per 100,000 population

• Male: 16.4
• Female: 5.0

Per 100,000 population

• Male: 15.7
• Female: 5.0

The Neglected Tropical Disease (NTD) list according to the World Health Organization (WHO) includes the following:

• Buruli ulcer
• Chagas disease
• Dengue and Chikungunya
• Dracunculiasis (guinea-worm disease)
• Echinococcosis
• Foodborne trematodiases
• Human African trypanosomiasis (sleeping sickness)
• Leishmaniasis
• Leprosy (Hansen's disease)
• Lymphatic filariasis
• Mycetoma, chromoblastomycosis
• Onchocerciasis (river blindness)
• Rabies
• Scabies and other ectoparasites
• Schistosomiasis
• Soil-transmitted helminthiases
• Snakebite envenoming
• Taeniasis/Cysticercosis
• Trachoma
• Yaws (Endemic treponematoses)

Only diseases reported to the Canadian Notifiable Disease Surveillance System (CNDSS) have been included as sub-indicators.

The Survey of Household Spending collects expenditures using two collection modes:  a questionnaire (using recall periods that vary based on the type of expenditure) and a two-week diary.

For methodological reasons, health care expenditures collected through the two-week diary were excluded from the numerator in the calculation of each household's proportion of income spent on health care. The excluded health care items are: non-prescribed medicines and pharmaceutical products; health care supplies; other health care equipment (i.e. other than major equipment); and non-prescription eye wear and other eye-care goods. Since these items were excluded, the definition of health care spending used for this indicator is therefore not consistent with the Classification of Individual Consumption According to Purpose (COICOP) classification.

The following out-of-pocket health care expenditures were included in the numerator: prescribed medicines and pharmaceutical products; major health care equipment (e.g. hearing aids, wheelchairs); health care services; prescription eye wear; eye-care services; and dental services.

Note that expenses for prescribed medicines and pharmaceutical products are collected through the questionnaire using a three-month recall period. Reported amounts are annualized so that they cover 12 months (they are multiplied by 4, and additional adjustments account for extreme values). The inclusion of annualized spending for prescribed medicines and pharmaceutical products in the numerator for this indicator requires the assumption that a given household's spending on this item does not vary between different three-month periods of the year.

After-tax household income was used for the denominator, since a measure of annual total consumption is not available at the individual household level due to design of the survey.

SHS estimates exclude households in Canada's three territories.

Disaggregation by sex

• Male: 3.1%
• Female: 3.8%

Disaggregation by age

• below 18 years: 2.2%
• 18 to 64 years: 3.0%
• 65 years or older: 6.6%

Disaggregation by income

• Adjusted household after-tax income in bottom 40%: 7.1%
• Adjusted household after-tax income in top 60%: 1.1%

Disaggregation by sex

• Male: 3.7%
• Female: 4.0%

Disaggregation by age

• below 18 years: 2.3%
• 18 to 64 years: 3.3%
• 65 years or older: 7.6%

Disaggregation by income

• Adjusted household after-tax income in bottom 40%: 7.4%
• Adjusted household after-tax income in top 60%: 1.5%

Disaggregation by sex

• Male: 0.8%
• Female: 0.9%

Disaggregation by age

• below 18 years: N/A
• 18 to 64 years: 0.8%
• 65 years or older: 1.3%

Disaggregation by income

• Adjusted household after-tax income in bottom 40%: 2.0%
• Adjusted household after-tax income in top 60%: N/A

Disaggregation by sex

• Male: 0.9%
• Female: 0.8%

Disaggregation by age

• below 18 years: N/A
• 18 to 64 years: 1.0%
• 65 years or older: 1.1%

Disaggregation by income

• Adjusted household after-tax income in bottom 40%: 1.9%
• Adjusted household after-tax income in top 60%: N/A

• Male: 74.1%
• Female: 77.5%

• Male: N/A
• Female: N/A

• Male: 74.1%
• Female: 77.5%

• Male: N/A
• Female: N/A

• Male: 74.1%
• Female: 77.5%

• Male: N/A
• Female: N/A

• Male: 90.0%
• Female: 91.4%

• Male: N/A
• Female: N/A

• Male: 72.1%
• Female: 74.7%

• Male: N/A
• Female: N/A

• Male: 89.9%
• Female: 91.6%

• Male: N/A
• Female: N/A

• Male: 88.8%
• Female: 91.1%

• Male: N/A
• Female: N/A

• Male: 88.8%
• Female: 91.1%

• Male: N/A
• Female: N/A

• Male: 82.1%
• Female: 83.8%

• Male: N/A
• Female: N/A

• Male: 87.1%
• Female: 88.3%

• Male: N/A
• Female: N/A

• Male: 80.1%
• Female: 82.6%

• Male: N/A
• Female: N/A

• Male: 78.3%
• Female: 79.3%

• Male: N/A
• Female: N/A